- Home
- LSF vs FORA Comparison
LSF vs FORA Comparison
Compare LSF & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | FORA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 66.2M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LSF | FORA |
|---|---|---|
| Price | $2.65 | $2.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 43.2K | 14.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,295,137.00 | $20,153,263.00 |
| Revenue This Year | $15.87 | $51.82 |
| Revenue Next Year | $14.98 | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.50 | N/A |
| 52 Week Low | $1.98 | $1.64 |
| 52 Week High | $7.94 | $2.71 |
Technical Indicators
Market Signals| Indicator | LSF | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 41.53 |
| Support Level | $1.98 | $2.05 |
| Resistance Level | $2.76 | $2.12 |
| Average True Range (ATR) | 0.19 | 0.02 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 18.86 | 10.00 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.